James J. Mullen, III

James J. Mullen, III

Morrison & Foerster LLP

Contact  |  View Bio  |  RSS

Latest Publications

Share:

After Myriad Oral Argument, Supreme Court Set to Decide Patentability of Isolated Human DNA Molecules

Today, the Supreme Court of the United States heard oral argument in Association for Molecular Pathology v. Myriad Genetics, Inc. (No. 12-398) to decide the question, “Are human genes patentable?” The Court’s decision in...more

4/16/2013 - AMP v Myriad DNA Gene Patenting Human Genes Oral Argument Patent-Eligible Subject Matter Patents SCOTUS

Australian Federal Court Upholds Myriad’s Gene Patent

While the question of patentability of isolated gene sequences awaits resolution at the U.S. Supreme Court, the Australian Federal Court today upheld Myriad Genetics’ patent on methods for screening for cancer-predisposing...more

2/19/2013 - DNA Gene Patenting Human Genes License Agreements Myriad Patent-Eligible Subject Matter RNA

Myriad Finally Gets Its Day in (the Supreme) Court

INTRODUCTION - The Supreme Court today granted certiorari in Assoc. for Molecular Pathology, et al. v. U.S. Patent and Trademark Office, et al. (Myriad), to address the issue of whether human genes are patentable. This...more

12/3/2012 - DNA Human Genes Myriad Patent-Eligible Subject Matter SCOTUS USPTO

3 Results
|
View per page
Page: of 1